University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin : The Randomized, Controlled EMPA-VISION Trial

dc.contributor.authorHundertmark, Moritz J
dc.contributor.authorAdler, Amanda
dc.contributor.authorAntoniades, Charalambos
dc.contributor.authorColeman, Ruth
dc.contributor.authorGriffin, Julian L
dc.contributor.authorHolman, Rury R
dc.contributor.authorLamlum, Hanan
dc.contributor.authorLee, Jisoo
dc.contributor.authorMassey, Daniel
dc.contributor.authorMiller, Jack J J J
dc.contributor.authorMilton, Joanne E
dc.contributor.authorMonga, Shveta
dc.contributor.authorMózes, Ferenc E
dc.contributor.authorNazeer, Areesha
dc.contributor.authorRaman, Betty
dc.contributor.authorRider, Oliver
dc.contributor.authorRodgers, Christopher T
dc.contributor.authorValkovič, Ladislav
dc.contributor.authorWicks, Eleanor
dc.contributor.authorMahmod, Masliza
dc.contributor.authorNeubauer, Stefan
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.date.accessioned2023-06-13T16:01:02Z
dc.date.available2023-06-13T16:01:02Z
dc.date.issued2023-05-30
dc.descriptionAcknowledgments The authors express their gratitude toward the Oxford cardiovascular magnetic resonance nursing team, specifically Judith DeLos Santos, Catherine Krasopoulos, Marion Galley, and Claudia Nunes; and the diabetes trials unit team, particularly Irene Kennedy, for her organization skills. The authors also thank the team of the computed tomography suite at the Manor Hospital Oxford as well as all patients who participated in this trial. Drs Holman and Neubauer are Emeritus National Institute for Health Research senior investigators. The views expressed are those of the author(s) and not necessarily those of the National Health Service, National Institute for Health and Care Research, or Department of Health. Sources of Funding Boehringer Ingelheim is the sponsor of the EMPA-VISION study and was involved in early stages of its study design. Boehringer Ingelheim employees (Drs Lee and Massey) also supported preparation of this manuscript. Dr Neubauer acknowledges support from the Oxford British Heart Foundation Centre of Research Excellence. Drs Holman and Neubauer were supported by the Oxford National Institute for Health Research Biomedical Research Centre. Drs Rodgers and Valkovič are funded by Sir Henry Dale Fellowships from the Wellcome Trust and the Royal Society [098436/Z/12/B and 221805/Z/20/Z, respectively]. Dr Valkovič also gratefully acknowledges support of the Slovak Grant Agencies VEGA (Vedecká grantová agentúra) [2/0003/20] and APVV (Slovak Research and Development Agency) [No. 19–0032]. Dr Miller acknowledges support from the Novo Foundation (NNF21OC0068683).en
dc.description.statusPeer revieweden
dc.format.extent15
dc.format.extent1262107
dc.identifier248546058
dc.identifier1540804f-3a52-4f4d-9ed8-d102a1ce79ec
dc.identifier37070436
dc.identifier85160841739
dc.identifier.citationHundertmark, M J, Adler, A, Antoniades, C, Coleman, R, Griffin, J L, Holman, R R, Lamlum, H, Lee, J, Massey, D, Miller, J J J J, Milton, J E, Monga, S, Mózes, F E, Nazeer, A, Raman, B, Rider, O, Rodgers, C T, Valkovič, L, Wicks, E, Mahmod, M & Neubauer, S 2023, 'Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin : The Randomized, Controlled EMPA-VISION Trial', Circulation, vol. 147, no. 22, pp. 1654-1669. https://doi.org/10.1161/CIRCULATIONAHA.122.062021en
dc.identifier.doi10.1161/CIRCULATIONAHA.122.062021
dc.identifier.issn0009-7322
dc.identifier.otherORCID: /0000-0003-1336-7744/work/136883008
dc.identifier.urihttps://hdl.handle.net/2164/20847
dc.language.isoeng
dc.relation.ispartofCirculationen
dc.subjectSubstantive link via an eligible employment contracten
dc.subjectR Medicineen
dc.subjectWellcome Trusten
dc.subject098436/Z/12/Ben
dc.subjectSupplementary Informationen
dc.subject.lccRen
dc.titleAssessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin : The Randomized, Controlled EMPA-VISION Trialen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Hundertmark_etal_C_Assessment_of_Cardiac_Energy_VOR.pdf
Size:
1.2 MB
Format:
Adobe Portable Document Format

Collections